Anti-Diabetic Nephropathy Activities of Polysaccharides Obtained from Termitornyces albuminosus via Regulation of NF-κB Signaling in db/db Mice

Int J Mol Sci. 2019 Oct 21;20(20):5205. doi: 10.3390/ijms20205205.

Abstract

Termitornyces albuminosus is a kind of traditional Chinese edible fungus rich in nutrients and medicinal ingredients, and it has anti-oxidative, analgesic and anti-inflammatory effects. However, the hypoglycemic and nephroprotective effects of polysaccharides separated from T. albuminosus (PTA) have not been reported. The properties of PTA were analyzed in a BKS.Cg-Dock7m +/+ Leprdb/JNju (db/db) mouse model of diabetes. After the administration of PTA for eight weeks, the hypoglycemic and hypolipidemic activities of PTA in the db/db mice were assessed. The results of a cytokine array combined with an enzyme-linked immunosorbent assay confirmed the anti-oxidative and anti-inflammatory activities of PTA. An eight-week administration of PTA caused hypoglycemic and hypolipidemic functioning, as indicated by suppressed plasma glucose levels, as well as the modulation of several cytokines related to glycometabolism, in the sera and kidneys of the mice. PTA treatment also had a protective effect on renal function, restoring renal structures and regulating potential indicators of nephropathy. In the kidneys of the db/db mice, PTA treatment reduced the activation of protein kinase B, the inhibitor of κB kinase alpha and beta, and the inhibitor of κB alpha and nuclear factor-κB (NF-κB). We establish the hypoglycemic, hypolipidemic, and anti-diabetic nephropathy effects of PTA, and we find that the renal protection effects of PTA may be related to anti-inflammatory activity via the regulation of NF-κB signaling.

Keywords: NF-κB; Termitornyces albuminosus; Type 2 diabetes mellitus; diabetic nephropathy; polysaccharides.

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Cytokines / metabolism
  • Diabetic Nephropathies / drug therapy*
  • Diabetic Nephropathies / genetics
  • Diabetic Nephropathies / metabolism
  • Disease Models, Animal
  • Fungal Polysaccharides / administration & dosage*
  • Fungal Polysaccharides / pharmacology
  • Gene Expression Regulation / drug effects
  • Male
  • Mice
  • NF-kappa B / metabolism
  • Receptors, Leptin / genetics
  • Signal Transduction / drug effects*
  • Termitomyces / metabolism*
  • Treatment Outcome

Substances

  • Blood Glucose
  • Cytokines
  • Fungal Polysaccharides
  • NF-kappa B
  • Receptors, Leptin
  • leptin receptor, mouse